Bio-Techne

TECH · NASDAQ

$72.58+$0.09 (+0.12%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $72.49

About TECH

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. The company is headquartered in Minneapolis, Minnesota and currently employs 3,100 full-time employees. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers. This segment also manufactures and sells fully automated multiomic spatial biology instrumentation and advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use.

Employees: 3,100
Headquarters: Minneapolis, Minnesota
Listed: Feb 9, 1989
Sector: Health Care
Industry: Life Sciences Tools & Services
Website: bio-techne.com

Leadership

Bio-Techne executives
Name	Title	Since	Age
Robert Baumgartner	—	—	69
Kim Kelderman	—	2018	58
James Hippel	—	—	54
Steve Crouse	—	—	52
William Geist	—	—	56
Matthew McManus	—	—	56
Shane Bohnen	—	—	50
Julie Bushman	—	—	64
Amy Herr	—	—	50
John Higgins	—	—	55
Joseph Keegan	—	—	72
Judith Klimovsky	—	—	69
Alpna Seth	—	—	62
Rupert Vessey	—	—	60
David Clair	—	2016	—

Revenue by product and region

Fiscal year ended Jun 30, 2024: $1.16B total revenue

By product

Represents the product and services provided by the company.$1.14B98.0%
Represents the information pertaining to consumables products.$928.18M80.1%
Represents the information pertaining to instruments which typically consist of longer-lived assets.$108.27M9.3%
Service [Member]$99.27M8.6%
Royalty [Member]$23.34M2.0%

By region

United States$657.75M56.7%
Regions of Europe, Middle East and Africa, excluding the United Kingdom.$241.43M20.8%
Greater China$99.47M8.6%
Represents the APAC, excluding Greater China.$73.90M6.4%
United Kingdom$50.01M4.3%
Rest of the geographical locations in the world.$36.50M3.1%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Bio-Techne suppliers and customers
Company	Relationship	Country	Correlation
C4 Therapeutics CCCC	Supplier and customer	US	0.88
Danaher DHR	Supplier	US	0.83
908 Devices MASS	Supplier and customer	US	0.79
Quanterix QTRX	Supplier and customer	US	0.75
Biohit B BIOBV.HE	Supplier	FI	0.71
Wave Life Sci Rg WVE	Supplier and customer	SG	0.68
Celcuity CELC	Customer	US	0.66
Renalytix RENX.L	Supplier and customer	GB	0.66
Xencor XNCR	Supplier and customer	US	0.64
Marker Therapeutics MRKR	Customer	US	0.58

Similar companies

Companies in the same industry as Bio-Techne

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.